I am studying a drug whose mechanism appears to be dependent on heat shock protein (HSP) function and I am attempting knockdown experiments to validate their independent implication.

Presently, I have had trouble with HSP72 knockdown in a glioblastoma cell line: controls with GAPDH siRNA using the same transfection protocol show >95% KD, however I can't get more than 5% KD of HSP72 using 3 different sequences targeted against the c-terminus (Ambion Silencer Select Pre-Designed series) using 100nM siRNA and measuring protein levels 48hrs following transfection (I am looking into transcript levels to see whether or not it is a protein stability issue).

In parallel, I'm considering HSP90 KD based on positive results with a pharmacological HSP90 inhibitor. Does anyone have experience with HSP90 KD? My initial worry about these experiments is that the level of cell viability will drop significantly given the dependence of cancer cell lines on HSP90 function.

Any comments, ideas, anecdotal experience is welcome and much appreciated. Thank you in advance.

Similar questions and discussions